5AMINO-10X
XENE BIOLABS RESEARCH SERIES
FOR RESEARCH USE ONLY
Category: Lipolytic Peptide | Half-life: 20-30 min
Mechanism
NNMT (Nicotinamide N-Methyltransferase) inhibitor. By inhibiting NNMT in adipose tissue, 5-Amino-1MQ increases intracellular NAD+ levels, activates SIRT1 and AMPK pathways, enhances energy expenditure, promotes fat cell shrinkage, and supports metabolic rate upregulation. No direct GH or IGF-1 effects.
Dosing Protocol
50–100 mg/day oral.
50 mg capsules:
- 50 mg/day = 1 capsule
- 100 mg/day = 2 capsules
Timing: Morning, with or without food.
Cycle Length: 8–12 weeks.
Critical: Daily consistency is important for optimal results. Fasting is not required. Best used alongside a calorie-controlled diet and regular exercise program to maximize metabolic and body-composition benefits.
5-Amino-1MQ
5AMINO-10X | NNMT Inhibitor / Metabolic Activator | CAS: 42464-96-0
5-Amino-1MQ is a small molecule inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme highly expressed in
adipose tissue that reduces NAD+ availability and impairs energy expenditure. By inhibiting NNMT, 5-Amino-1MQ raises
intracellular NAD+, activates SIRT1, boosts AMPK, and drives fat cell shrinkage and metabolic rate upregulation
| Parameter | Details |
|---|---|
| Dose | 50–100 mg per day (oral) |
| Timing | Morning, with or without food |
| Cycle Length | 8–12 weeks |
| Form | Capsule / Oral |
STACKING RECOMMENDATIONS
Synergistic with MOTS-c (AMPK convergence), NAD+ supplementation (substrate support), Retatrutide or HGH Frag
(fat-loss amplification), and Berberine. Excellent metabolic triple-stack: 5-Amino-1MQ + MOTS-c + Berberine.
NOTE: Oral administration — most convenient in lineup. Raises NAD+ indirectly. Stack with NMN or NR for substrate augmentation
From Collection
AOD-9604 | AOD-X
XENE BIOLABS RESEARCH SERIES
FOR RESEARCH USE ONLY
Category: Lipolytic Peptide | Half-life: 20-30 min
Mechanism
Modified hGH Frag 176-191 | FRAG-X. Tyr-hGH 177-191. Same fat-burning domain as Frag, stabilized. No GH/IGF-1 effects.
Dosing Protocol
Reconstitution: 2 mg + 1 mL BAC = 2 mg/mL. 300 mcg = 0.15 mL = 15 units.
Critical: Identical to hGH Frag 176-191 | FRAG-X. Must be fasted. Insulin blocks effect.
HGH FRAG- 5X
XENE BIOLABS RESEARCH SERIES
FOR RESEARCH USE ONLY
Category: Lipolytic Peptide | Half-life: 20-30 min
Mechanism
Modified hGH Frag 176-191 | FRAG-X. Tyr-hGH 177-191. Same fat-burning domain as Frag, stabilized. No GH/IGF-1 effects.
Dosing Protocol
Reconstitution: 2 mg + 1 mL BAC = 2 mg/mL. 300 mcg = 0.15 mL = 15 units.
Critical: Identical to hGH Frag 176-191 | FRAG-X. Must be fasted. Insulin blocks effect.
TB500
XENE BIOLABS RESEARCH SERIES
FOR RESEARCH USE ONLY
Category: Lipolytic Peptide | Half-life: 20-30 min
Mechanism
Modified hGH Frag 176-191 | FRAG-X. Tyr-hGH 177-191. Same fat-burning domain as Frag, stabilized. No GH/IGF-1 effects.
Dosing Protocol
Reconstitution: 2 mg + 1 mL BAC = 2 mg/mL. 300 mcg = 0.15 mL = 15 units.
Critical: Identical to hGH Frag 176-191 | FRAG-X. Must be fasted. Insulin blocks effect.